KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Long-Term Investments (2020 - 2025)

Historic Long-Term Investments for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $2.7 billion.

  • Oscar Health's Long-Term Investments rose 1015.42% to $2.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.7 billion, marking a year-over-year increase of 1015.42%. This contributed to the annual value of $2.7 billion for FY2025, which is 1015.42% up from last year.
  • As of Q4 2025, Oscar Health's Long-Term Investments stood at $2.7 billion, which was up 1015.42% from $2.6 billion recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Long-Term Investments ranged from a high of $2.8 billion in Q2 2025 and a low of $165.2 million during Q1 2023
  • Over the past 5 years, Oscar Health's median Long-Term Investments value was $820.8 million (recorded in 2021), while the average stood at $1.1 billion.
  • As far as peak fluctuations go, Oscar Health's Long-Term Investments tumbled by 7656.44% in 2022, and later surged by 97657.95% in 2024.
  • Oscar Health's Long-Term Investments (Quarter) stood at $844.5 million in 2021, then crashed by 73.6% to $222.9 million in 2022, then skyrocketed by 373.33% to $1.1 billion in 2023, then skyrocketed by 131.22% to $2.4 billion in 2024, then increased by 10.15% to $2.7 billion in 2025.
  • Its Long-Term Investments stands at $2.7 billion for Q4 2025, versus $2.6 billion for Q3 2025 and $2.8 billion for Q2 2025.